Novo Nordisk’s Oral Wegovy Defies Gravity as FDA Poised to Curb Compounders
Novo Nordisk’s new Wegovy pill generates 2.26B DKK in Q1, double forecasts; revenue jumps 32% to 96.82B DKK.…
FDA Crackdown and Oral Ozempic Launch Set Stage for Earnings
Novo Nordisk enters a pivotal week with an FDA shortage-list victory, oral Ozempic rollout, and partnerships to capture…
FDA Curbs Copycats as Oral Ozempic Hits 70,000 Pharmacies
Novo Nordisk gains 6% as FDA targets cheap semaglutide copies and launches first oral GLP-1 tablet in the…
FDA Curbs Copycats as Ozempic Pill Replaces Rybelsus
Novo Nordisk gains nearly 5% as FDA targets copycat weight-loss drugs and rebrands Rybelsus as the ‘Ozempic pill’…
Novo Nordisk Caught Between FDA Tailwind and a Brutal Revenue Outlook
FDA proposal to curb cheap copycats boosts Novo Nordisk shares 4.8%, but pricing pressure, competition, and a grim…
Novo Nordisk Juggles Pipeline Wins and Core Business Headwinds
Novo Nordisk advances rare heart disease drug Coramitug with FDA Fast Track, reports positive oral semaglutide data in…
Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?
Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
Novo Nordisk’s Buyback Blitz and FDA Fast-Track Mask a Steep Profit Slide
Novo Nordisk spends billions on share repurchases but faces a 50% stock drop, 2026 revenue decline, and fierce…
FDA Approves Foundayo, a New Oral Weight-Loss Drug Like Ozempic
The U.S. Food and Drug Administration (FDA). Credit: Felton Davis / CC BY 2.0 The U.S. Food and…
Breakthrough in Weight Loss: Novo Nordisk’s High-Dose Wegovy
Novo Nordisk has announced the U.S. release of a higher-dose version of their weight-loss drug, Wegovy. The…
Novo Nordisk shares resilient as FDA approves Eli Lilly GLP-1 weight-loss pill to intensify competition
Novo Nordisk shares resilient as FDA approves Eli Lilly GLP-1 weight-loss pill to intensify competition Proactive uses images…
Novo Nordisk Shares Down 43% in a Year as Generic Rivals Force 48% Price Cuts
clubfoto / Getty Images Quick Read Novo Nordisk (NVO) cut Wegovy and Ozempic prices up to 48% in…